Current Alzheimer Research

ISSN 1567-2050

Current Alzheimer Research publishes peer-reviewed frontier review and research articles on all areas of Alzheimer's disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer's disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer's disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer's disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer's disease. Current Alzheimer Research provides a comprehensive 'bird's-eye view' of the current state of Alzheimer's research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

Publisher: Bentham Science Publishers

Cholinesterase Inhibitors and Beyond
pp. 86-96(11)
Authors: Pepeu, Giancarlo; Giovannini, Maria G.

Responders to ChEI Treatment of Alzheimer's Disease Show Restitution of Normal Regional Cortical Activation
pp. 97-111(15)
Authors: Venneri, Annalena; McGeown, William J.; Shanks, Michael F.

M1 Agonists as a Potential Disease-Modifying Therapy for Alzheimer's Disease
pp. 112-117(6)
Authors: Caccamo, Antonella; Fisher, Abraham; LaFerla, Frank M.

GEPT Extract Reduces Aβ Deposition by Regulating the Balance Between Production and Degradation of Aβ in APPV717I Transgenic Mice
pp. 118-131(14)
Authors: Tian, Jinzhou; Shi, Jing; Zhang, Leiming; Yin, Junxiang; Hu, Quan; Xu, Yi; Sheng, Shuli; Wang, Pengwen; Ren, Ying; Wang, Rong; Wang, Yongyan

Oligomeric Amyloid β -Protein as a Therapeutic Target in Alzheimer's Disease: Its Significance Based on its Distinct Localization and the Occurrence of a Familial Variant Form
pp. 132-136(5)
Authors: Ito, Kazuhiro; Ishibashi, Ken-Ichi; Tomiyama, Takami; Umeda, Tomohiro; Yamamoto, Kei-Ichi; Kitajima, Erika; Idomoto, Toshiki; Nagatomo, Toshie; Mori, Hiroshi

Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
pp. 144-151(8)
Authors: Vellas, Bruno; Black, R.; Thal, Leon J.; Fox, Nick C.; Daniels, M.; McLennan, G.; Tompkins, C.; Leibman, C.; Pomfret, M.; Grundman, Michael

Early Tau Pathology Involving the Septo-Hippocampal Pathway in a Tau Transgenic Model: Relevance to Alzheimer's Disease
pp. 152-157(6)
Authors: Belarbi, Karim; Schindowski, Katharina; Burnouf, Sylvie; Caillierez, Raphaelle; Grosjean, Marie-Eve; Demeyer, Dominique; Hamdane, Malika; Sergeant, Nicolas; Blum, David; Buee, Luc

Development of a Non Invasive NGF-Based Therapy for Alzheimer's Disease
pp. 158-170(13)
Authors: Covaceuszach, Sonia; Capsoni, Simona; Ugolini, Gatsuella; Spirito, F.; Vignone, D.; Cattaneo, Antonio

Natural Non-Trasgenic Animal Models for Research in Alzheimer's Disease
pp. 171-178(8)
Authors: Sarasa, Manuel; Pesini, Pedro

Structural and Functional MRI in Mild Cognitive Impairment
pp. 179-185(7)
Authors: Pihlajamaki, Maija; Jauhiainen, Anne M.; Soininen, Hilkka

Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.